Prostate – Adenocarcinoma (Gleason 4+4) with focal KRT7 positivity.
Prostate - Adenocarcinoma (Gleason 4+4) with focal KRT7 positivity. 
Stomach – Gastric adenocarcinoma (intestinal type) with strong KRT7 immunostaining.
Stomach - Gastric adenocarcinoma (intestinal type) with strong KRT7 immunostaining. 
Breast – Invasive breast cancer of no special type with strong KRT7 immunostaining in all tumor cells.
Breast - Invasive breast cancer of no special type with strong KRT7 immunostaining in all tumor cells. 
Kidney – Clear cell renal cell carcinoma with weak focal KRT7 positivity.
Kidney - Clear cell renal cell carcinoma with weak focal KRT7 positivity. 
Kidney – KRT7 negative clear cell renal cell carcinoma.
Kidney - KRT7 negative clear cell renal cell carcinoma.
Colo – KRT7 negative colorectal adenocarcinoma.
Colon - KRT7 negative colorectal adenocarcinoma. 
Stomach – KRT7 positive gastric adenocarcinoma (diffuse type).
Stomach - KRT7 positive gastric adenocarcinoma (diffuse type). 
Breast – Strong KRT7 expression in a lobular breast cancer.
Breast - Strong KRT7 expression in a lobular breast cancer. 
Liver – Strong KRT7 immunostaining of all cells of a cholangiocellular carcinoma.
Liver - Strong KRT7 immunostaining of all cells of a cholangiocellular carcinoma. 
Kidney – Strong KRT7 immunostaining of all cells of a chromophobe carcinoma.
Kidney - Strong KRT7 immunostaining of all cells of a chromophobe carcinoma. 
Thyroid – Strong KRT7 positivity in a follicular carcinoma.
Thyroid - Strong KRT7 positivity in a follicular carcinoma.